Effects of Exercise Behavior Modification on Plasma Adiponectin and Insulin Resistance in High Risk Subjects of Diabetes

Clinical Trial ID NCT01136096

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01136096

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002 101.79
2 Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001 56.11
3 Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 1997 23.95
4 Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999 14.25
5 Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000 9.85
6 Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 2000 6.96
7 Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 2009 5.08
8 Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA 2003 4.76
9 Prevention of type II diabetes by physical training. Epidemiological considerations and study methods. Diabetes Care 1992 0.76
10 Home-based exercise may not decrease the insulin resistance in individuals with metabolic syndrome. J Phys Act Health 2014 0.75
Next 100